semaglutide oral side effects for diabetes and obesity treatment Summary of practical guidance for

doi:10.1002/iub.2507 Xu M, Zhu Y, Chen J, et al

Regulators reference factors such as high blood pressure, dyslipidaemia, cardiovascular disease, prediabetes, type 2 diabetes and obstructive sleep apnoea when assessing eligibility for prescription weight-management treatment, so your medical context is part of the decision

On-Label Usage (MFDS / KFDA Standard): Preventing nervous system symptoms resulting from cisplatin or similar chemical treatments

Semaglutide, on the other hand, has been extensively studied and is approved by the FDA for weight loss

Professional Advice: Consult your healthcare provider before use if you are pregnant, nursing, have a medical condition, or are taking any medications